• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于手动勾勒的容积评估法用于评估伴有肝脏局限性转移的结直肠癌:与RECIST的比较

Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST.

作者信息

Fang W J, Lam K O, Ng S C Y, Choi C W, Kwong D L W, Zheng S S, Lee V H F

机构信息

First Affiliated Hospital, School of Medicine, Zhe Jiang University, China.

出版信息

Asian Pac J Cancer Prev. 2013;14(7):4151-5. doi: 10.7314/apjcp.2013.14.7.4151.

DOI:10.7314/apjcp.2013.14.7.4151
PMID:23991968
Abstract

BACKGROUND

To compare response evaluation criteria in solid tumours (RECIST) and volumetric evaluation (VE) for colorectal cancer with liver-limited metastasis.

PATIENTS AND METHODS

VE of liver metastases was performed by manual contouring before and after chemotherapy on 45 pairs of computed tomography (CT) images in 36 patients who suffered from metastatic colorectal cancer (mCRC) with liver metastasis only. Cohen kappa was used to compare the agreement between VE and RECIST. Pearson correlation was performed for their comparison after cubic root transformation of the aggregate tumor volumes. Logistic regression was done to identify clinical and radiographic factors to account for the difference which may be predictive in overall response (OR).

RESULTS

There were 16 partial response (PR), 23 stable disease (SD) and 6 progressive disease (PD) cases with VE, and 14 PR, 23 SD and 8 PD with RECIST. VE demonstrated good agreement with RECIST (κ=0.779). Discordant objective responses were noted in 6 pairs of comparisons (13.3%). Pearson correlation also showed excellent correlation between VE and RECIST (r2=0.966, p<0.001). Subgroup analysis showed that VE was in slightly better agreement with RECIST for enlarging lesions than for shrinking lesions (r2=0.935 and r2=0.780 respectively). No factor was found predictive of the difference in OR between VE and RECIST.

CONCLUSIONS

VE exhibited good agreement with RECIST. It might be more useful than RECIST in evaluation shrinking lesions in cases of numerous and conglomerate liver metastases.

摘要

背景

比较实体瘤疗效评价标准(RECIST)与体积评估(VE)在仅发生肝转移的结直肠癌中的应用。

患者与方法

对36例仅发生肝转移的转移性结直肠癌(mCRC)患者的45对计算机断层扫描(CT)图像进行化疗前后肝脏转移灶的手动轮廓勾画,以进行VE评估。采用Cohen κ检验比较VE与RECIST之间的一致性。对总体肿瘤体积进行立方根转换后,采用Pearson相关性分析进行比较。进行逻辑回归分析以确定可能预测总体反应(OR)差异的临床和影像学因素。

结果

VE评估有16例部分缓解(PR)、23例疾病稳定(SD)和6例疾病进展(PD);RECIST评估有14例PR、23例SD和8例PD。VE与RECIST显示出良好的一致性(κ=0.779)。在6对比较(13.3%)中观察到客观反应不一致。Pearson相关性分析也显示VE与RECIST之间具有极好的相关性(r2=0.966,p<0.001)。亚组分析表明,对于增大病变,VE与RECIST的一致性略优于缩小病变(分别为r2=0.935和r2=0.780)。未发现可预测VE与RECIST之间OR差异的因素。

结论

VE与RECIST显示出良好的一致性。在评估肝转移灶数目众多且融合的病例中的缩小病变时,VE可能比RECIST更有用。

相似文献

1
Manual contouring based volumetric evaluation for colorectal cancer with liver limited metastases: a comparison with RECIST.基于手动勾勒的容积评估法用于评估伴有肝脏局限性转移的结直肠癌:与RECIST的比较
Asian Pac J Cancer Prev. 2013;14(7):4151-5. doi: 10.7314/apjcp.2013.14.7.4151.
2
Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.采用传统化疗和抗血管生成化疗治疗的结直肠癌肝转移:肝脏计算机断层扫描灌注成像和磁共振扩散加权成像评估
J Comput Assist Tomogr. 2011 Nov-Dec;35(6):690-6. doi: 10.1097/RCT.0b013e318230d905.
3
Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.肿瘤生长动力学与实体瘤疗效评价标准对比以评估乳腺癌肝转移局部区域治疗的反应
Acad Radiol. 2014 Aug;21(8):950-7. doi: 10.1016/j.acra.2014.02.015. Epub 2014 May 13.
4
Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.早期 PET/CT 扫描比 RECIST 更能预测接受贝伐珠单抗联合术前化疗治疗的结直肠癌肝转移患者的预后。
J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17.
5
Comparison of RECIST 1.0 and RECIST 1.1 on computed tomography in patients with metastatic colorectal cancer.比较 1.0 和 1.1 在转移性结直肠癌患者 CT 上的 RECIST。
Oncology. 2014;86(2):117-21. doi: 10.1159/000357714. Epub 2014 Jan 25.
6
Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.结直肠癌肝转移患者的疗效评价:RECIST 1.1 版与改良 CT 标准的比较。
AJR Am J Roentgenol. 2012 Oct;199(4):809-15. doi: 10.2214/AJR.11.7910.
7
Comparing RECIST with EORTC criteria in metastatic bladder cancer.在转移性膀胱癌中比较RECIST标准与欧洲癌症研究与治疗组织(EORTC)标准。
J Cancer Res Clin Oncol. 2016 Jan;142(1):187-94. doi: 10.1007/s00432-015-2022-2. Epub 2015 Jul 25.
8
Non Size Based Morphology Criteria for Assessment of Response in Patients with Liver Metastases of Gastrointestinal Origin Receiving Systemic Treatment.基于非大小形态学标准评估接受全身治疗的胃肠道源性肝转移患者的反应
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1655-1660. doi: 10.22034/APJCP.2018.19.6.1655.
9
Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.CT 形态学变化可作为接受regorafenib 治疗结直肠癌肝转移患者的独立应答标志物:回顾性初步研究。
BMC Cancer. 2018 Feb 5;18(1):138. doi: 10.1186/s12885-018-4067-5.
10
Radiological heterogeneity in response to chemotherapy is associated with poor survival in patients with colorectal liver metastases.化疗后影像学异质性与结直肠癌肝转移患者的生存不良相关。
Eur J Cancer. 2013 Jul;49(11):2486-93. doi: 10.1016/j.ejca.2013.03.027. Epub 2013 May 18.

引用本文的文献

1
Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.使用三维超声评估结直肠癌肝转移的治疗反应:基于CT图像的个性化三维打印肿瘤模型的应用
PLoS One. 2017 Aug 10;12(8):e0182596. doi: 10.1371/journal.pone.0182596. eCollection 2017.
2
Colorectal cancer with Synchronous liver-limited Metastases: the protocol of an Inception Cohort study (CoSMIC).伴有同步性肝局限性转移的结直肠癌:一项初始队列研究(CoSMIC)的方案
BMJ Open. 2017 Jun 9;7(6):e015018. doi: 10.1136/bmjopen-2016-015018.